# RadNet, Inc.: financial statements, quarterly

RDNT · Nasdaq · CIK 790526 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rdnt.md) · [Financials](/companies/rdnt/financials.md) · [Filings](/companies/rdnt/filings.md) · [Insiders](/companies/rdnt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rdnt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [402](/filings/0001628280-24-047285.md) | [420 d](/filings/0001628280-26-013337.md) | [432](/filings/0001628280-25-024672.md) | [460](/filings/0001628280-25-039605.md) | [461](/filings/0000790526-25-000008.md) | [477 d](/filings/0001628280-26-013337.md) | [471](/filings/0001628280-26-033607.md) | [498](/filings/0001628280-26-055338.md) | [523](/filings/0000790526-25-000008.md) | [548 d](/filings/0001628280-26-013337.md) | [576](/filings/0001628280-26-033607.md) | [623](/filings/0001628280-26-055338.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [43.3](/filings/0001628280-24-047285.md) | [24.3 d](/filings/0001628280-26-013337.md) | [11.3](/filings/0001628280-25-024672.md) | [34.8](/filings/0001628280-25-039605.md) | [33.9](/filings/0000790526-25-000008.md) | [24.5 d](/filings/0001628280-26-013337.md) | [(24.1)](/filings/0001628280-26-033607.md) | [30.9](/filings/0001628280-26-055338.md) | [27.4](/filings/0000790526-25-000008.md) | [27.8 d](/filings/0001628280-26-013337.md) | [(23.9)](/filings/0001628280-26-033607.md) | [39.5](/filings/0001628280-26-055338.md) |
| Income tax | $m | [7.2](/filings/0001628280-24-047285.md) | [0.7 d](/filings/0001628280-26-013337.md) | [(1.9)](/filings/0001628280-25-024672.md) | [2.5](/filings/0001628280-25-039605.md) | [4.3](/filings/0000790526-25-000008.md) | [1.1 d](/filings/0001628280-26-013337.md) | [(3.4)](/filings/0001628280-26-033607.md) | [0.8](/filings/0001628280-26-055338.md) | [6.4](/filings/0000790526-25-000008.md) | [11.1 d](/filings/0001628280-26-013337.md) | [(8.1)](/filings/0001628280-26-033607.md) | [6.4](/filings/0001628280-26-055338.md) |
| Net income | $m | [17.5](/filings/0001628280-24-047285.md) | [(1.9) d](/filings/0001628280-26-013337.md) | [(2.8)](/filings/0001628280-25-024672.md) | [(3.0)](/filings/0001628280-25-039605.md) | [3.2](/filings/0000790526-25-000008.md) | [5.3 d](/filings/0001628280-26-013337.md) | [(37.9)](/filings/0001628280-26-033607.md) | [14.5](/filings/0001628280-26-055338.md) | [5.4](/filings/0000790526-25-000008.md) | [(0.6) d](/filings/0001628280-26-013337.md) | [(33.5)](/filings/0001628280-26-033607.md) | [7.5](/filings/0001628280-26-055338.md) |
| Diluted EPS | $ per share | [0.25](/filings/0001628280-24-047285.md) | not reported | [(0.04)](/filings/0001628280-25-024672.md) | [(0.04)](/filings/0001628280-25-039605.md) | [0.04](/filings/0000790526-25-000008.md) | not reported | [(0.51)](/filings/0001628280-26-033607.md) | [0.19](/filings/0001628280-26-055338.md) | [0.07](/filings/0000790526-25-000008.md) | not reported | [(0.43)](/filings/0001628280-26-033607.md) | [0.10](/filings/0001628280-26-055338.md) |
| Basic EPS | $ per share | [0.26](/filings/0001628280-24-047285.md) | not reported | [(0.04)](/filings/0001628280-25-024672.md) | [(0.04)](/filings/0001628280-25-039605.md) | [0.04](/filings/0000790526-25-000008.md) | not reported | [(0.51)](/filings/0001628280-26-033607.md) | [0.19](/filings/0001628280-26-055338.md) | [0.07](/filings/0000790526-25-000008.md) | not reported | [(0.43)](/filings/0001628280-26-033607.md) | [0.10](/filings/0001628280-26-055338.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [338](/filings/0001628280-23-038345.md) | [343](/filings/0001628280-25-009481.md) | [527](/filings/0001628280-24-022619.md) | [742](/filings/0001628280-24-036466.md) | [749](/filings/0001628280-24-047285.md) | [740](/filings/0001628280-26-013337.md) | [717](/filings/0001628280-25-024672.md) | [833](/filings/0001628280-25-039605.md) | [805](/filings/0000790526-25-000008.md) | [767](/filings/0001628280-26-055338.md) | [455](/filings/0001628280-26-033607.md) | [726](/filings/0001628280-26-055338.md) |
| Current assets | $m | [579](/filings/0001628280-23-038345.md) | [579](/filings/0001628280-25-009481.md) | [796](/filings/0001628280-24-022619.md) | [1,005](/filings/0001628280-24-036466.md) | [1,016](/filings/0001628280-24-047285.md) | [1,019](/filings/0001628280-26-013337.md) | [1,016](/filings/0001628280-25-024672.md) | [1,094](/filings/0001628280-25-039605.md) | [1,078](/filings/0000790526-25-000008.md) | [1,032](/filings/0001628280-26-055338.md) | [741](/filings/0001628280-26-033607.md) | [1,036](/filings/0001628280-26-055338.md) |
| Total assets | $m | [2,688](/filings/0001628280-23-038345.md) | [2,690](/filings/0001628280-25-009481.md) | [2,970](/filings/0001628280-24-022619.md) | [3,229](/filings/0001628280-24-036466.md) | [3,275](/filings/0001628280-24-047285.md) | [3,287](/filings/0001628280-26-013337.md) | [3,336](/filings/0001628280-25-024672.md) | [3,515](/filings/0001628280-25-039605.md) | [3,665](/filings/0000790526-25-000008.md) | [3,759](/filings/0001628280-26-055338.md) | [3,885](/filings/0001628280-26-033607.md) | [4,226](/filings/0001628280-26-055338.md) |
| Current liabilities | $m | [407](/filings/0001628280-23-038345.md) | [437](/filings/0001628280-25-009481.md) | [428](/filings/0001628280-24-022619.md) | [474](/filings/0001628280-24-036466.md) | [470](/filings/0001628280-24-047285.md) | [480](/filings/0001628280-26-013337.md) | [505](/filings/0001628280-25-024672.md) | [546](/filings/0001628280-25-039605.md) | [575](/filings/0000790526-25-000008.md) | [587](/filings/0001628280-26-055338.md) | [636](/filings/0001628280-26-033607.md) | [698](/filings/0001628280-26-055338.md) |
| Total liabilities | $m | [1,892](/filings/0001628280-23-038345.md) | [1,877](/filings/0001628280-25-009481.md) | [1,892](/filings/0001628280-24-022619.md) | [2,137](/filings/0001628280-24-036466.md) | [2,156](/filings/0001628280-24-047285.md) | [2,153](/filings/0001628280-26-013337.md) | [2,200](/filings/0001628280-25-024672.md) | [2,336](/filings/0001628280-25-039605.md) | [2,351](/filings/0000790526-25-000008.md) | [2,403](/filings/0001628280-26-055338.md) | [2,533](/filings/0001628280-26-033607.md) | [2,832](/filings/0001628280-26-055338.md) |
| Long-term debt | $m | [844](/filings/0001628280-23-038345.md) | [812](/filings/0001628280-25-009481.md) | [814](/filings/0001628280-24-022619.md) | [1,002](/filings/0001628280-24-036466.md) | [996](/filings/0001628280-24-047285.md) | [992](/filings/0001628280-26-013337.md) | [985](/filings/0001628280-25-024672.md) | [1,077](/filings/0001628280-25-039605.md) | [1,071](/filings/0000790526-25-000008.md) | [1,064](/filings/0001628280-26-055338.md) | [1,060](/filings/0001628280-26-033607.md) | [1,302](/filings/0001628280-26-055338.md) |
| Current portion of debt | $m | [16.0](/filings/0001628280-23-038345.md) | [18.0](/filings/0001628280-25-009481.md) | [20.2](/filings/0001628280-24-022619.md) | [24.2](/filings/0001628280-24-036466.md) | [23.4](/filings/0001628280-24-047285.md) | [24.7](/filings/0001628280-26-013337.md) | [24.7](/filings/0001628280-25-024672.md) | [25.5](/filings/0001628280-25-039605.md) | [25.5](/filings/0000790526-25-000008.md) | [25.4](/filings/0001628280-26-055338.md) | [26.5](/filings/0001628280-26-033607.md) | [30.7](/filings/0001628280-26-055338.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [619](/filings/0001628280-23-038345.md) | [631](/filings/0001628280-25-009481.md) | [873](/filings/0001628280-24-022619.md) | [881](/filings/0001628280-24-036466.md) | [895](/filings/0001628280-24-047285.md) | [902](/filings/0001628280-26-013337.md) | [898](/filings/0001628280-25-024672.md) | [932](/filings/0001628280-25-039605.md) | [1,059](/filings/0000790526-25-000008.md) | [1,090](/filings/0001628280-26-055338.md) | [1,081](/filings/0001628280-26-033607.md) | [1,096](/filings/0001628280-26-055338.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.3 d](/filings/0001628280-24-047285.md) | [88.9 d](/filings/0001628280-26-013337.md) | [17.1](/filings/0001628280-25-024672.md) | [116 d](/filings/0001628280-25-039605.md) | [57.4 d](/filings/0000790526-25-000008.md) | [42.5 d](/filings/0001628280-26-013337.md) | [41.5](/filings/0001628280-26-033607.md) | [120 d](/filings/0001628280-26-055338.md) | [52.8 d](/filings/0000790526-25-000008.md) | [84.2 d](/filings/0001628280-26-013337.md) | [79.0](/filings/0001628280-26-033607.md) | [94.1 d](/filings/0001628280-26-055338.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.7](/filings/0001628280-23-038345.md) | [57.7](/filings/0001628280-24-022619.md) | [60.9](/filings/0001628280-24-036466.md) | [68.8](/filings/0001628280-24-047285.md) | [69.3](/filings/0001628280-25-024672.md) | [73.4](/filings/0001628280-25-039605.md) | [75.2](/filings/0000790526-25-000008.md) | [74.4](/filings/0001628280-26-033607.md) | [75.5](/filings/0001628280-26-055338.md) | [77.4](/filings/0000790526-25-000008.md) | [77.1](/filings/0001628280-26-033607.md) | [78.7](/filings/0001628280-26-055338.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 78,697,257 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055338.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.